Sensemaker

Denmark’s gold rush town

If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype? Writer: Claudia WilliamsProducer: Claudia WilliamsPhotography: Joe MeeExecutive producer: Rebecca Moore Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.

The Sensemaker from The Observer - one story every day to make sense of the world. Subscribe to <a href="https://observer.co.uk/" rel="noopener noreferrer" target="_blank">The Observer </a>today and get access to: Our podcasts before anyone else A daily edition, curated by our editors 7 days a week Puzzles from the inventors of the cryptic crossword Recipes for every occasionFree tickets to join Observer events in our newsroom or online Click <a href="observer.co.uk/subscribe" rel="noopener noreferrer" target="_blank">here</a> to subscribe today for just £1 for your first month. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.